Does Rallies show 13F holders for EHC?

Yes. Rallies tracks hedge fund and 13F ownership data for EHC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is EHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EHC. It does not provide personalized investment advice.

EHC (Encompass Health Corporation Common Stock) Stock Analysis - Hedge Fund Holdings

Encompass Health Corporation Common Stock (EHC) is a publicly traded Healthcare sector company. As of May 21, 2026, EHC trades at $105.99 with a market cap of $10.53B and a P/E ratio of 17.35. EHC moved +1.20% today. Year to date, EHC is -1.61%; over the trailing twelve months it is -12.93%. Its 52-week range spans $87.85 to $127.99. Analyst consensus is strong buy with an average price target of $141.25. Rallies surfaces EHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns EHC stock?

Hedge funds tracked by Rallies that own EHC include Glenview Capital, Bridgewater Associates, Davidson Kempner, Pinebridge Investments, and Centerbook Partners. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Encompass Health Corporation Common Stock.

EHC Key Metrics

Key financial metrics for EHC
Metric	Value
Price	$105.99
Market Cap	$10.53B
P/E Ratio	17.35
EPS	$6.08
Dividend Yield	0.19%
52-Week High	$127.99
52-Week Low	$87.85
Volume	0
Avg Volume	0
Revenue (TTM)	$6.07B
Net Income	$810.80M
Gross Margin	0.00%

Top Hedge Funds Holding EHC

Glenview Capital holds 167.64K shares of EHC, changed +0.00% as of Sep 30, 2025.
Bridgewater Associates holds 46.41K shares of EHC, changed +31.15% as of Mar 31, 2026.
Davidson Kempner holds 18.20K shares of EHC, changed +0.00% as of Mar 31, 2026.
Pinebridge Investments holds 13.22K shares of EHC, changed -3.93% as of Sep 30, 2025.
Centerbook Partners holds 5.60K shares of EHC, changed +0.00% as of Dec 31, 2023.

Latest EHC News

Encompass Health Prices $500M of 5.875% Senior Notes Due 2034 — May 14, 2026
Encompass Health to Open 50-Bed Rehab Hospital in Idaho by 2028 — May 11, 2026
Encompass Health Opens 50-Bed, 66,000-Square-Foot Rehab Hospital in Concordville, PA — May 5, 2026
Encompass Health drops 3% as post-earnings rally fades amid fund-selling filing — May 5, 2026
Encompass Health jumps as Q1 results top expectations and 2026 guidance rises — May 1, 2026

Recent EHC Insider Trades

COLTHARP DOUGLAS E sold 27.69K (~$2.96M) on May 15, 2026.
COLTHARP DOUGLAS E sold 1 (~$107.28) on May 15, 2026.
Tuer Patrick William sold 682 (~$71.31K) on May 11, 2026.

EHC Analyst Consensus

6 analysts cover EHC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $141.25.

Common questions about EHC

Who owns EHC stock?: Hedge funds tracked by Rallies that own EHC include Glenview Capital, Bridgewater Associates, Davidson Kempner, Pinebridge Investments, and Centerbook Partners. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Encompass Health Corporation Common Stock.
Does Rallies show 13F holders for EHC?: Yes. Rallies tracks hedge fund and 13F ownership data for EHC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is EHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EHC. It does not provide personalized investment advice.